Sinil Pharmaceutical Shares Owned By Institutions vs. Shares Owned By Insiders
| 012790 Stock | KRW 6,260 260.00 4.33% |
For Sinil Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sinil Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sinil Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sinil Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sinil Pharmaceutical Co over time as well as its relative position and ranking within its peers.
Sinil |
Sinil Pharmaceutical Shares Owned By Insiders vs. Shares Owned By Institutions Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Sinil Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Sinil Pharmaceutical value to that of its competitors to determine the firm's financial worth.Sinil Shares Owned By Insiders vs. Shares Owned By Institutions
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Sinil Pharmaceutical |
| = | 0.58 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Sinil Pharmaceutical |
| = | 40.12 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Sinil Shares Owned By Insiders Comparison
Sinil Pharmaceutical is currently under evaluation in shares owned by insiders category among its peers.
Sinil Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Sinil Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Sinil Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Sinil Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Sinil Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Sinil Pharmaceutical Co., Ltd. manufactures, markets, and sells pharmaceutical products in South Korea. Sinil Pharmaceutical Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea. Shinil Pharm is traded on Korean Securities Dealers Automated Quotations in South Korea.
Sinil Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Sinil Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Sinil Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Sinil Pharmaceutical's important profitability drivers and their relationship over time.
Use Sinil Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sinil Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinil Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Sinil Pharmaceutical Pair Trading
Sinil Pharmaceutical Co Pair Trading Analysis
The ability to find closely correlated positions to Sinil Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sinil Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sinil Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sinil Pharmaceutical Co to buy it.
The correlation of Sinil Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sinil Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sinil Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sinil Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Sinil Pharmaceutical position
In addition to having Sinil Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Developed Markets Basket ETFs Thematic Idea Now
Developed Markets Basket ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Developed Markets Basket ETFs theme has 24 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Developed Markets Basket ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Sinil Stock
To fully project Sinil Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Sinil Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Sinil Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.